Page 2 - நிகழ்நிலை முதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As India eyes Sputnik rollout, experts question efficacy data SECTIONS Share Synopsis The experts expressed concern regarding the availability of the data from which the Sputnik investigators drew their conclusions as they had refused to share it. A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow. Picture credit: ( Reuters ) (This story originally appeared in on May 14, 2021)HYDERABAD: Even as India is gearing up to roll out Russian Covid-19 vaccine Sputnik V next week, a group of international experts has raised serious questions about the data discrepancies and substandard reporting of interim data of the vaccine’s phase 3 trials. Raising the red flag on discrepancies in the trials data, changes in the trial protocols, quality and accuracy of data as well as a lack of transparency, they said: “Restricted access to data hampers trust in research. Access to data underpinning study findings is imperative to che

Andhra pradeshRussian direct investment fundOnline firstஆந்திரா பிரதேஷ்ரஷ்ய நேரடி முதலீடு நிதிநிகழ்நிலை முதல்